Skip to main content

LCD L33633: Magnetic Resonance Angiography (MRA)

LCD L33633, Magnetic Resonance Angiography (MRA), is the Local Coverage Determination that Wellpoint Federal applies to claims from 10 states (CT, IL, MA, ME, MN, NH, NY, RI and others), effective 2026-04-01 and first in force 2015-10-01. The policy text runs 550 words, and its billing and coding article A56747 lists 1,193 ICD-10-CM codes that support medical necessity for 30 procedure codes. 3 other contractor versions share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 1,193 covered ICD-10-CM codes: 118 fewer codes than L34424 (Palmetto GBA, 1,311 codes, revised 2025-03-27) and 194 more codes than L34865 (Novitas Solutions, Inc., 999 codes, revised 2020-07-01).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Wellpoint Federal
States and territories
10
CT IL MA ME MN NH NY RI VT WI
Revision effective
2026-04-01
Original effective
2015-10-01
Policy text
550 words
Covered ICD-10 codes (articles)
1193

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L33633
ContractContractorTypeStates
06101Wellpoint FederalMAC - Part AIL
06201Wellpoint FederalMAC - Part AMN
06301Wellpoint FederalMAC - Part AWI
06102Wellpoint FederalMAC - Part BIL
06202Wellpoint FederalMAC - Part BMN
06302Wellpoint FederalMAC - Part BWI
13101Wellpoint FederalA and B and HHH MACCT
13201Wellpoint FederalA and B and HHH MACNY
13102Wellpoint FederalA and B and HHH MACCT
13202Wellpoint FederalA and B and HHH MACNY
13282Wellpoint FederalA and B and HHH MACNY
13292Wellpoint FederalA and B and HHH MACNY
14411Wellpoint FederalA and B and HHH MACRI
14211Wellpoint FederalA and B and HHH MACMA
14311Wellpoint FederalA and B and HHH MACNH
14511Wellpoint FederalA and B and HHH MACVT
14111Wellpoint FederalA and B and HHH MACME
14112Wellpoint FederalA and B and HHH MACME
14212Wellpoint FederalA and B and HHH MACMA
14312Wellpoint FederalA and B and HHH MACNH
14512Wellpoint FederalA and B and HHH MACVT
14412Wellpoint FederalA and B and HHH MACRI

Billing and coding article A56747: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A56747 (Billing and Coding: Magnetic Resonance Angiography (MRA)) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A56747: Billing and Coding: Magnetic Resonance Angiography (MRA) (Billing and Coding, effective 2026-04-01)

Covered ICD-10-CM codes
1193
4 groups
Non-covered ICD-10-CM codes
0
Procedure codes listed
30
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A56747
ICD-10-CMDescription (FY2027)
A52.01Syphilitic aneurysm of aorta
A52.19Other symptomatic neurosyphilis
C64.1Malignant neoplasm of right kidney, except renal pelvis
C64.2Malignant neoplasm of left kidney, except renal pelvis
C65.1Malignant neoplasm of right renal pelvis
C65.2Malignant neoplasm of left renal pelvis
C68.8Malignant neoplasm of overlapping sites of urinary organs
C69.01Malignant neoplasm of right conjunctiva
C69.02Malignant neoplasm of left conjunctiva
C69.11Malignant neoplasm of right cornea
C69.12Malignant neoplasm of left cornea
C69.21Malignant neoplasm of right retina
C69.22Malignant neoplasm of left retina
C69.31Malignant neoplasm of right choroid
C69.32Malignant neoplasm of left choroid
C69.41Malignant neoplasm of right ciliary body
C69.42Malignant neoplasm of left ciliary body
C69.51Malignant neoplasm of right lacrimal gland and duct
C69.52Malignant neoplasm of left lacrimal gland and duct
C69.61Malignant neoplasm of right orbit
C69.62Malignant neoplasm of left orbit
C69.81Malignant neoplasm of overlapping sites of right eye and adnexa
C69.82Malignant neoplasm of overlapping sites of left eye and adnexa
C70.0Malignant neoplasm of cerebral meninges

Procedure codes: 70544, 70545, 70546, 70547, 70548, 70549, 71555, 72159, 72198, 73225, 73725, 74185, C8900 (Magnetic resonance angiography with contrast, abdomen), C8901 (Magnetic resonance angiography without contrast, abdomen), C8902 (Magnetic resonance angiography without contrast followed by with contrast, abdomen), C8909 (Magnetic resonance angiography with contrast, chest (excluding myocardium)), C8910 (Magnetic resonance angiography without contrast, chest (excluding myocardium)), C8911 (Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)), C8912 (Magnetic resonance angiography with contrast, lower extremity), C8913 (Magnetic resonance angiography without contrast, lower extremity), C8914 (Magnetic resonance angiography without contrast followed by with contrast, lower extremity), C8918 (Magnetic resonance angiography with contrast, pelvis), C8919 (Magnetic resonance angiography without contrast, pelvis), C8920 (Magnetic resonance angiography without contrast followed by with contrast, pelvis), C8931 (Magnetic resonance angiography with contrast, spinal canal and contents), C8932 (Magnetic resonance angiography without contrast, spinal canal and contents), C8933 (Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents), C8934 (Magnetic resonance angiography with contrast, upper extremity), C8935 (Magnetic resonance angiography without contrast, upper extremity), C8936 (Magnetic resonance angiography without contrast followed by with contrast, upper extremity).

Coverage indications, limitations and medical necessity

Indications:

Please refer to Article A56747, Billing and Coding: Magnetic Resonance Angiography, for national coverage provisions.

Head and Neck

All of the following criteria must apply in order for Medicare to provide coverage for MRA of the head and neck:

• MRA is used to evaluate the carotid arteries, the circle of Willis, the anterior, middle or posterior cerebral arteries, the vertebral or basilar arteries or the venous sinuses;

• MRA is performed on patients with conditions of the head and neck for which surgery is anticipated and may be found to be appropriate based on the MRA. These conditions include, but are not limited to, tumor, aneurysms, vascular malformations, vascular occlusion or thrombosis. Within this broad category of disorders, medical necessity is the underlying determinant of the need for an MRA in specific diseases. The medical records should clearly justify and demonstrate the existence of medical necessity; and,

• MRA and CA are not expected to be performed on the same patient for diagnostic purposes prior to the application of anticipated therapy. Only one of these tests will be covered routinely unless the physician can demonstrate the medical need to perform both tests.

MRA is appropriately used to verify the presence of a condition, suspected because of findings from another test (usually an imaging study). For example, a patient who presents with a transient ischemic attack (TIA) should not undergo MRA simply because he might have a lesion which is amenable to surgery. However, if that patient has a carotid bruit and is found by Doppler study to have carotid stenosis, an MRA may be appropriate to evaluate the stenotic section of artery for surgical intervention. Please note that the anticipated surgery may be a percutaneous procedure such as carotid angioplasty with stent insertion.

Another patient may present with a headache; it is not appropriate to proceed directly to MRA to rule out the possibility of an intracranial aneurysm. However, if that patient was found to have a clinically significant amount of blood in the cerebrospinal fluid, or the patient demonstrated signs and symptoms strongly suggesting an unruptured intracranial aneurysm, an MRA (or cerebral angiogram) may be appropriate. An MRA is not considered medically necessary for screening asymptomatic patients for intracranial aneurysms.

Please note that the anticipated surgery may be a percutaneous procedure such as carotid angioplasty with stent insertion.

Peripheral Arteries of Lower Extremities

• Both MRA and CA may be useful in some cases, such as:

A patient has had CA and this test was unable to identify a viable run-off vessel for bypass. When exploratory surgery is not believed to be a reasonable medical course of action for this patient, MRA may be performed to identify the viable runoff vessel; or,

• A patient has had MRA, but the results are inconclusive.

Abdomen and Pelvis

An MRA of the abdomen for evaluation of possible renal artery stenosis would not be considered medically necessary without some evidence consistent with renovascular hypertension. Such evidence might include:

• a history of early or late onset of hypertension, hypertension refractory to medication, or worsening renal function;

• the presence of a renal artery bruit;

• laboratory tests (elevated serum renins, increasing creatinine); or

• other radiologic tests (ultrasound, captopril scintigraphy, or other imaging showing small kidney or unequal kidney sizes).

Summary of evidence (opening)

N/A

the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2026-04-01
Last reviewed by the contractor
2017-03-09
MCD version
50
Derived from
L25367

The contractor lists 2 National Coverage Determinations as related: NCD 220.2 Magnetic Resonance Imaging, NCD 220.3 Magnetic Resonance Angiography - RETIRED. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Wellpoint Federal hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L33633 cover?

All of the following criteria must apply in order for Medicare to provide coverage for MRA of the head and neck: The full 550-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L33633 apply to?

Wellpoint Federal applies it to Medicare claims in 10 states: CT, IL, MA, ME, MN, NH, NY, RI, VT, WI. It binds only that contractor; 3 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L33633?

The companion billing and coding article A56747 lists 1,193 ICD-10-CM codes in 4 groups that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L33633?

A denial under LCD L33633 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A56747's 1,193 covered diagnosis codes, then file a redetermination with Wellpoint Federal within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.